perylene has been researched along with Brain Neoplasms in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (15.00) | 18.2507 |
| 2000's | 7 (35.00) | 29.6817 |
| 2010's | 8 (40.00) | 24.3611 |
| 2020's | 2 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bassler, MC; Brecht, M; Meixner, AJ; Rammler, T; Ritz, R; Secic, I; Wackenhut, F; Zur Oven-Krockhaus, S | 1 |
| Fan, Z; Guan, J; He, P; Ji, C; Liu, C; Ouyang, Q; Qin, M; Yin, M; Zhang, W | 1 |
| Choi, C; Chong, K; Jon, S; Ku, T; Park, JH; Saw, PE | 1 |
| Ehrhardt, A; Feigl, GC; Göbel, W; Mayer, D; Naumann, U; Noell, S; Ritz, R; Serifi, D | 1 |
| Bu, L; Cheng, K; Cheng, Z; Fan, Q; Hu, X; Huang, W; Lu, X; Ma, X; Xiong, X; Yang, M; Yang, Z; Zhang, R; Zhao, H | 1 |
| Agostinis, P; Boon, L; Garg, AD; Koks, C; Van Gool, SW; Vandenberk, L; Verschuere, T | 1 |
| Dzurova, L; Horvath, D; Huntosova, V; Joniova, J; Miskovsky, P; Misuth, M; Nichtova, Z; Novotova, M; Stroffekova, K | 1 |
| Shibata, Y | 1 |
| Mayer, D; Noell, S; Ritz, R; Strauss, WS; Tatagiba, MS | 1 |
| Appley, AJ; Cabana, BE; Chen, TC; Couldwell, WT; Forsyth, PA; Hinton, DR; Spence, AM; Stillerman, CB; Surnock, AA; Tobia, AJ | 1 |
| Bornemann, A; Daniels, R; Dietz, K; Feigl, GC; Mayer, D; Noell, S; Ramina, K; Ritz, R; Schmidt, V; Strauss, WS; Tatagiba, M | 1 |
| Deininger, MH; Meyermann, R; Morgalla, MH; Schluesener, HJ; Weinschenk, T | 1 |
| Chen, TC; Fry, D; Liebes, L; Su, S | 1 |
| Gajdos, M; Kocanová, S; Lavicka, J; Mirossay, A; Mirossay, L; Miskovsky, P; Mojzis, J; Sarissky, M; Sulla, I | 1 |
| Chen, TC; Gupta, V; Hofman, FM; Kardosh, A; Liebes, LF; Schönthal, AH; Su, YS; Wang, W | 1 |
| Dietz, K; Ritz, R; Roser, F; Schenk, M; Strauss, WS; Tatagiba, M; Wein, HT | 1 |
| Bornemann, A; Dietz, K; Duffner, F; Müller, M; Ritz, R; Roser, F; Tatagiba, M | 1 |
| Apuzzo, ML; Couldwell, WT; Gopalakrishna, R; He, S; Hinton, DR; Law, RE; Weiss, MH | 1 |
| Couldwell, WT; Hinton, DR; Surnock, AA; Zhang, W | 1 |
| Couldwell, WT; Hinton, DR; Law, RE; Zhang, W | 1 |
1 review(s) available for perylene and Brain Neoplasms
| Article | Year |
|---|---|
Release of regulators of angiogenesis following Hypocrellin-A and -B photodynamic therapy of human brain tumor cells.
Topics: Angiogenesis Inducing Agents; Blotting, Western; Brain Neoplasms; Electrophoresis, Polyacrylamide Gel; Humans; Mass Spectrometry; Perylene; Phenol; Photochemotherapy; Photosensitizing Agents; Quinones; Tumor Cells, Cultured | 2002 |
1 trial(s) available for perylene and Brain Neoplasms
| Article | Year |
|---|---|
A phase 1/2 study of orally administered synthetic hypericin for treatment of recurrent malignant gliomas.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anthracenes; Antineoplastic Agents; Brain Neoplasms; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Perylene | 2011 |
18 other study(ies) available for perylene and Brain Neoplasms
| Article | Year |
|---|---|
Accumulation and penetration behavior of hypericin in glioma tumor spheroids studied by fluorescence microscopy and confocal fluorescence lifetime imaging microscopy.
Topics: Anthracenes; Brain Neoplasms; Cell Line, Tumor; Glioma; Humans; Microscopy, Fluorescence; Perylene; Photosensitizing Agents | 2022 |
NIR-II Perylene Monoimide-Based Photothermal Agent with Strengthened Donor-Acceptor Conjugation for Deep Orthotopic Glioblastoma Phototheranostics.
Topics: Blood-Brain Barrier; Brain Neoplasms; Glioblastoma; Humans; Nanoparticles; Perylene; Phototherapy; Theranostic Nanomedicine | 2023 |
Enhancement of the photocytotoxic efficiency of sub-12 nm therapeutic polymeric micelles with increased co-localisation in mitochondria.
Topics: Anthracenes; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Humans; Light; Micelles; Mitochondria; Nanoparticles; Perylene; Phosphatidylethanolamines; Photochemotherapy; Photosensitizing Agents; Polyethylene Glycols | 2013 |
Microendoscopy for hypericin fluorescence tumor diagnosis in a subcutaneous glioma mouse model.
Topics: Animals; Anthracenes; Brain Neoplasms; Cell Line, Tumor; Disease Models, Animal; Endoscopy; Glioma; Metabolic Clearance Rate; Mice; Perylene; Photosensitizing Agents; Reproducibility of Results; Sensitivity and Specificity; Skin Neoplasms; Spectrometry, Fluorescence; Tissue Distribution | 2013 |
Perylene-diimide-based nanoparticles as highly efficient photoacoustic agents for deep brain tumor imaging in living mice.
Topics: Animals; Brain Neoplasms; Cell Survival; Contrast Media; Diagnostic Imaging; Imides; Mice; Micelles; Nanoparticles; NIH 3T3 Cells; Perylene; Photoacoustic Techniques | 2015 |
Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma.
Topics: Adaptive Immunity; Animals; Anthracenes; Apoptosis; Brain Neoplasms; Cancer Vaccines; CD8-Positive T-Lymphocytes; Cell Death; Dendritic Cells; Endoplasmic Reticulum Stress; Glioma; Mice; Mice, Inbred C57BL; Neoplasm Grading; Perylene; Photochemotherapy; Reactive Oxygen Species; T-Lymphocytes, Cytotoxic | 2016 |
The flashlights on a distinct role of protein kinase C δ: Phosphorylation of regulatory and catalytic domain upon oxidative stress in glioma cells.
Topics: Algorithms; Anthracenes; Apoptosis; Brain Neoplasms; Catalytic Domain; Cell Line, Tumor; Glioma; Humans; Light; Microscopy, Electron; Microscopy, Fluorescence; Mitochondria; Oxidative Stress; Perylene; Phosphorylation; Protein Kinase C-delta; Proto-Oncogene Proteins c-bcl-2 | 2017 |
Comment on "Hypericin uptake: a prognostic marker for survival in high-grade glioma".
Topics: Anthracenes; Brain Neoplasms; Glioma; Humans; Perylene | 2009 |
Selective enrichment of hypericin in malignant glioma: pioneering in vivo results.
Topics: Animals; Anthracenes; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Glioma; Male; Neoplasm Transplantation; Perylene; Rats; Rats, Wistar | 2011 |
Hypericin for visualization of high grade gliomas: first clinical experience.
Topics: Aged; Anthracenes; Brain Neoplasms; Female; Fluorescence; Glioma; Humans; Injections, Intravenous; Male; Middle Aged; Perylene; Photosensitizing Agents; Predictive Value of Tests; Sensitivity and Specificity | 2012 |
Combination therapy with irinotecan and protein kinase C inhibitors in malignant glioma.
Topics: Anthracenes; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2-Associated X Protein; Brain Neoplasms; Camptothecin; Cell Line; Glioblastoma; Humans; Irinotecan; Naphthalenes; Perylene; Protein Kinase C; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Staurosporine; Tamoxifen; Tumor Cells, Cultured | 2003 |
Diazepam enhances hypericin-induced photocytotoxicity and apoptosis in human glioblastoma cells.
Topics: Adult; Aged; Anthracenes; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Diazepam; Drug Interactions; Female; Flow Cytometry; GABA Modulators; Glioblastoma; Humans; Male; Middle Aged; Perylene; Photochemotherapy; Tumor Cells, Cultured | 2005 |
Enhancement of glioblastoma cell killing by combination treatment with temozolomide and tamoxifen or hypericin.
Topics: Animals; Anthracenes; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Brain Neoplasms; Cell Cycle Proteins; Cell Line, Tumor; Cell Survival; Dacarbazine; Disease Models, Animal; Down-Regulation; Drug Synergism; Glioblastoma; Growth Inhibitors; Humans; Male; Mice; Mice, Nude; Perylene; Tamoxifen; Temozolomide; Transplantation, Heterologous; Treatment Outcome | 2006 |
Photodynamic therapy of malignant glioma with hypericin: comprehensive in vitro study in human glioblastoma cell lines.
Topics: Anthracenes; Brain Neoplasms; Cell Line, Tumor; Cell Membrane; Glioblastoma; Glioma; Humans; Light; Microscopy, Fluorescence; Perylene; Photochemotherapy; Photosensitizing Agents; Time Factors | 2007 |
Hypericin uptake: a prognostic marker for survival in high-grade glioma.
Topics: Adult; Aged; Anthracenes; Astrocytoma; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Disease-Free Survival; Drug Resistance, Neoplasm; Drug Therapy; Female; Fluorescence; Glioblastoma; Glioma; Humans; Light; Lipoproteins, LDL; Male; Microscopy, Fluorescence; Middle Aged; Models, Statistical; Perylene; Photochemotherapy; Predictive Value of Tests; Prognosis; Radiation-Sensitizing Agents; Radiotherapy; Survival Rate | 2008 |
Hypericin: a potential antiglioma therapy.
Topics: Anthracenes; Apoptosis; Brain Neoplasms; Cell Division; Cell Line; Cell Survival; DNA Damage; Dose-Response Relationship, Drug; Glioma; Humans; Perylene; Phototherapy; Protein Kinase C; Radiation-Sensitizing Agents; Tumor Cells, Cultured | 1994 |
Malignant glioma sensitivity to radiotherapy, high-dose tamoxifen, and hypericin: corroborating clinical response in vitro: case report.
Topics: Adult; Anthracenes; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Brain Neoplasms; Cell Division; Chemotherapy, Adjuvant; Combined Modality Therapy; Cranial Irradiation; Craniotomy; Dominance, Cerebral; Dose-Response Relationship, Drug; Female; Frontal Lobe; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasm, Residual; Perylene; Radiotherapy, Adjuvant; Reoperation; Tamoxifen; Tumor Cells, Cultured | 1996 |
Inhibition of human malignant glioma cell motility and invasion in vitro by hypericin, a potent protein kinase C inhibitor.
Topics: Anthracenes; Antineoplastic Agents; Brain Neoplasms; Cell Movement; Cells, Cultured; Enzyme Inhibitors; Glioma; Humans; Neoplasm Invasiveness; Perylene; Protein Kinase C | 1997 |